Giles A - Search Results

1

College of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy: laboratory monitoring of unfractionated heparin therapy.

Olson JD, Arkin CF, Brandt JT, Cunningham MT, Giles A, Koepke JA, Witte DL. Olson JD, et al. Among authors: giles a. Arch Pathol Lab Med. 1998 Sep;122(9):782-98. Arch Pathol Lab Med. 1998. PMID: 9740136 Review.

2

By what mechanisms could prothrombin complex concentrates promote factor VIII bypassing activity in vivo?

Giles AR. Giles AR. Transfus Med Rev. 1987 Aug;1(2):131-7. doi: 10.1016/s0887-7963(87)70013-3. Transfus Med Rev. 1987. PMID: 2980270 Review. No abstract available.

3

Neutrophil elastase cleavage of human factor IX generates an activated factor IX-like product devoid of coagulant function.

Samis JA, Kam E, Nesheim ME, Giles AR. Samis JA, et al. Among authors: giles ar. Blood. 1998 Aug 15;92(4):1287-96. Blood. 1998. PMID: 9694717 Free article.

4

Anticoagulant and fibrinolytic activities are promoted, not retarded, in vivo after thrombin generation in the presence of a monoclonal antibody that inhibits activation of protein C.

Taylor FB Jr, Hoogendoorn H, Chang AC, Peer G, Nesheim ME, Catlett R, Stump DC, Giles AR. Taylor FB Jr, et al. Among authors: giles ar. Blood. 1992 Apr 1;79(7):1720-8. Blood. 1992. PMID: 1558968 Free article.

5

The utility of activated partial thromboplastin time (aPTT) clot waveform analysis in the investigation of hemophilia A patients with very low levels of factor VIII activity (FVIII:C).

Shima M, Matsumoto T, Fukuda K, Kubota Y, Tanaka I, Nishiya K, Giles AR, Yoshioka A. Shima M, et al. Among authors: giles ar. Thromb Haemost. 2002 Mar;87(3):436-41. Thromb Haemost. 2002. PMID: 11916076

6

Functional, biochemical, and morphological evaluations of experimental hemophilia therapies in animal models.

Giles AR. Giles AR. Semin Hematol. 1994 Apr;31(2 Suppl 4):56-9. Semin Hematol. 1994. PMID: 7939778 Review. No abstract available.

7

The canine factor VIII cDNA and 5' flanking sequence.

Cameron C, Notley C, Hoyle S, McGlynn L, Hough C, Kamisue S, Giles A, Lillicrap D. Cameron C, et al. Among authors: giles a. Thromb Haemost. 1998 Feb;79(2):317-22. Thromb Haemost. 1998. PMID: 9493583

8

Aortic endothelial cell von Willebrand factor content, and circulating plasminogen activator inhibitor-1 are increased, but expression of endothelial leukocyte adhesion molecules is unchanged in insulin-dependent diabetic BB rats.

Ribau JC, Samis JA, Senis YA, Maurice DH, Giles AR, DeReske M, Absher PM, Hatton MW, Richardson M. Ribau JC, et al. Among authors: giles ar. Atherosclerosis. 2000 Apr;149(2):331-42. doi: 10.1016/s0021-9150(99)00344-5. Atherosclerosis. 2000. PMID: 10729383

9

Cosegregation of von Willebrand factor gene polymorphisms and possible germinal mosaicism in type IIB von Willebrand disease.

Murray EW, Giles AR, Bridge PJ, Peake IR, Lillicrap DP. Murray EW, et al. Among authors: giles ar. Blood. 1991 Apr 1;77(7):1476-83. Blood. 1991. PMID: 2009368 Free article.

10

Non-overt disseminated intravascular coagulation: introduction.

Giles AR. Giles AR. Blood Rev. 2002 Dec;16 Suppl 1:S1. Blood Rev. 2002. PMID: 12918780 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

452 results

Search Page